Mohamad Mohty to Hodgkin Disease
This is a "connection" page, showing publications Mohamad Mohty has written about Hodgkin Disease.
Connection Strength
0.295
-
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party. Cancer. 2019 01 01; 125(1):90-98.
Score: 0.151
-
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party. Br J Haematol. 2018 04; 181(1):86-96.
Score: 0.144